Form 4: Twist Bioscience CFO Adam Laponis Sells Shares to Cover Tax Obligations

Adam Laponis, CFO of Twist Bioscience, sold 556 shares of common stock on April 9, 2024, to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• On April 9, 2024, Adam Laponis, the Chief Financial Officer of Twist Bioscience Corp, sold 556 shares of the company's common stock.
• The sale was executed at a price of $33.155 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units.
• Following the transaction, Laponis directly owns 74,444 shares of Twist Bioscience Corp.
• The sale was mandated by Twist Bioscience's equity incentive plans, requiring tax withholding obligations to be funded through a 'sell to cover' transaction.

Sentiment

Score: 5

Explanation: Neutral sentiment as the filing relates to a routine transaction for tax purposes and doesn't indicate any fundamental change in the company's prospects.

Industry Context

This is a routine Form 4 filing, indicating insider activity related to stock transactions. It is common for executives to sell shares to cover tax obligations related to vesting equity.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates